MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-14-2025
Biomerica DSO Ratio 2011-2025 | BMRA
Annual DSO Ratio Biomerica
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.7 | 56.2 | 51.1 | 21.6 | 81.7 | 96.3 | 102 | 52.5 | 66.8 | 68.8 | 81.8 | 103 | 49.2 | 72.1 | 55.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 21.6 | 67.8 |
Quarterly DSO Ratio Biomerica
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64 | - | 106 | 80.2 | 63.1 | - | 98.6 | 72.7 | 57.3 | - | 65.9 | 54.9 | 47.5 | 28.3 | 13.6 | 18.6 | 80.5 | 22.5 | 38.6 | 106 | 134 | 117 | 122 | 61.2 | 88.4 | 83.2 | 104 | 69.1 | 65 | 48.6 | 66.5 | 59.4 | 66.6 | 31.6 | 66.9 | 67.2 | 62.7 | 61.8 | 69.3 | 93.5 | 82.4 | 87.1 | 59.4 | 54.4 | 98.6 | 117 | 100 | 84.2 | 79.9 | 85.1 | 107 | 69.8 | 69 | 58.1 | 62.5 | 56.4 | 52.3 | 42.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 134 | 13.6 | 71.3 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 16.38 | 3.97 % | $ 170 M |  China |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.6 | -1.23 % | $ 2.03 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
49.2 | $ 39.39 | 1.97 % | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
57 | $ 228.73 | 0.98 % | $ 167 B | USA |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 11.97 | 0.67 % | $ 340 M |  Israel |
 |
DexCom
DXCM
|
85 | $ 67.19 | 0.34 % | $ 25.9 B | USA |
 |
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.46 | -0.04 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 27.23 | 0.31 % | $ 823 M | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 20.72 | 0.78 % | $ 1.11 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.41 | -4.75 % | $ 109 K | USA |
 |
Co-Diagnostics
CODX
|
101 | $ 0.33 | -3.34 % | $ 9.68 M | USA |
 |
Quidel Corporation
QDEL
|
116 | $ 28.72 | -0.28 % | $ 1.21 B | USA |
 |
Guardant Health
GH
|
49.2 | $ 103.82 | 1.72 % | $ 12.7 B | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 223.38 | 0.52 % | $ 40.5 B | USA |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 135.16 | 0.22 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 197.73 | 2.46 % | $ 10.2 B | USA |
 |
Quotient Limited
QTNT
|
45.1 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 184.0 | 0.82 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 7.85 | - | $ 1.02 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 264.75 | 0.22 % | $ 22.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 187.27 | 0.37 % | $ 15.4 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
43.6 | $ 707.12 | 0.41 % | $ 58.3 B | USA |
 |
Lantheus Holdings
LNTH
|
72 | $ 66.85 | 0.35 % | $ 4.63 B | USA |
 |
Agilent Technologies
A
|
63.8 | $ 140.96 | 0.93 % | $ 42.9 B | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 405.6 | 0.84 % | $ 29.8 B | Schweiz |
 |
Myriad Genetics
MYGN
|
51.3 | $ 7.22 | 0.14 % | $ 654 M | USA |
 |
Bioventus
BVS
|
92.3 | $ 7.64 | 1.13 % | $ 479 M | USA |
 |
NeoGenomics
NEO
|
77.8 | $ 11.87 | 0.16 % | $ 1.5 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 6.82 | -0.66 % | $ 1.48 B | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | Israel |